Standard UK Delivery from £2.49

Please enable cookies to use this site. Why?

Inflacam

Inflacam Chewable Tablets can be used to reduce post-operative pain and inflammation following ovariohysterectomy (in cats), orthopaedic and minor soft tissue surgery. Moreover, they can be used to lessen inflammation and pain in acute and chronic musculo-skeletal disorders in both cats and dogs.

Inflacam Tablets are pale yellow in colour, and have been single-scored so that they can be divided into equal halves for easy and accurate dosing.

Loading...
Inflacam 1mg Chewable Tablets for Dogs

Inflacam 1mg Chewable Tablets for Dogs

£0.22

Inflacam 1mg Chewable Tablets are indicated for the alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders. They can be used to reduce post-operative pain...[More info]

£0.22
Inflacam 2.5mg Chewable Tablets for Dogs

Inflacam 2.5mg Chewable Tablets for Dogs

£0.46

Inflacam 2.5mg Chewable Tablets are indicated for the alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders. They can be used to reduce post-operative...[More info]

£0.46

Contra-indications
Do not use in pregnant or lactating animals.
Do not use in dogs suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Do not use in dogs less than 6 weeks of age or less than 4 kg body weight.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Special warnings for each target species
None

Special precautions for use
Special precautions for use in animals
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDS) should avoid contact with the veterinary medicinal product.
In the case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Adverse reactions
Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, lethargy and renal failure have occasionally been reported.
In very rare cases, haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported.
These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.

Use during pregnancy, lactation or lay
The safety of the veterinary medicinal product has not been established during pregnancy and lactation.

Interactions
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. Inflacam must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such medicines should be observed for at least 24 hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacokinetic properties of the products used previously.

Amounts to be administered and administration route
Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day.
Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.
Each chewable tablet contains either 1 mg or 2.5 mg meloxicam, which corresponds to the daily maintenance dose for a 10 kg body weight dog, or a 25 kg body weight dog respectively.
Each chewable tablet can be halved for accurate dosing according to the individual body weight of the animal.
Inflacam chewable tablets can be administered with or without food, are flavoured and are taken by most dogs voluntarily.
The use of Inflacam oral suspension for dogs may be considered for an even more precise dosing. For dogs weighing less than 4 kg the use of Inflacam oral suspension for dogs is recommended.
A clinical response is normally seen within 3–4 days. Treatment should be discontinued after 10 days if no clinical improvement is apparent.

Overdose
In case of overdose symptomatic treatment should be initiated.

Withdrawal periods
Not applicable